✦ LIBER ✦

PReS-FINAL-2033: Increase of adverse mild and moderate adverse events among patients with juvenile idiopathic arthritis treated with biological therapies

✍ Scribed by Guillen Astete, CA; García Campayo, L; Conde Campayo, B; Sifuentes Giraldo, A; Gamir Gamir, ML

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PReS-FINAL-2088: Risk of severe adverse

✍ Vatta, P; Taddio, A; Lepore, L; Moressa, V; Naviglio, S; Prinzi, E 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 101 KB

Oc016—Off-Label Use And Adverse Events O

✍ Broe, J.; Platz, M.A.; Nielsen, S.; Christensen, H.R.; Holst, H. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB